MwanzoADVM • NASDAQ
add
Adverum Biotechnologies Inc
Bei iliyotangulia
$ 4.36
Bei za mwaka
$ 1.78 - $ 6.07
Thamani ya kampuni katika soko
96.26M USD
Wastani wa hisa zilizouzwa
elfu 498.47
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 46.94M | 36.66% |
Mapato halisi | -47.65M | -47.30% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -2.03 | -56.15% |
EBITDA | -47.56M | -41.76% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 26.06M | -82.99% |
Jumla ya mali | 72.40M | -69.11% |
Jumla ya dhima | 128.05M | 41.87% |
Jumla ya hisa | -55.65M | — |
hisa zilizosalia | 22.08M | — |
Uwiano wa bei na thamani | -1.72 | — |
Faida inayotokana na mali | -142.43% | — |
Faida inayotokana mtaji | -228.05% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -47.65M | -47.30% |
Pesa kutokana na shughuli | -28.12M | -33.10% |
Pesa kutokana na uwekezaji | 1.86M | 113.92% |
Pesa kutokana na ufadhili | 9.90M | — |
Mabadiliko halisi ya pesa taslimu | -16.36M | 52.54% |
Mtiririko huru wa pesa | -11.26M | 25.10% |
Kuhusu
Adverum Biotechnologies, Inc. is a publicly traded clinical stage gene therapy company located in Redwood City, California. It is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Ilianzishwa
1 Jan 2006
Makao Makuu
Tovuti
Wafanyakazi
155
